Guided Bone Regeneration of Peri-implant Defects Comparing Submerged Versus Non-submerged Healing

April 2, 2019 updated by: Ana Molina Villar

Guided Bone Regeneration of Peri-implant Defects Comparing Submerged Versus Non-submerged Healing: a Randomized Controlled Clinical Trial

Objective: the objective of the present randomized clinical trial is to compare changes in radiographic peri-implant bone defect fill after regeneration of peri-implant intrabony defects with a submerged versus a non-submerged protocol.

Material and Methods: this project is a randomized controlled clinical trial, double blind, with a parallel groups design. Thirty-six patients presenting with peri-implantitis subsidiary of regenerative treatment will be recruited. After subjects have been given informed consent, they will be randomized to test or control group. All patients will undergo a session of non-surgical peri-implantitis therapy consisting on prostheses removal and implant debridement with ultrasounds, curettes and air-abrasive under local anaesthesia. Patients in test group will have their prostheses removed and the mucosa surrounding the affected implants will be let heal covering the implants, while patients in control group will have their prostheses installed again after the non-surgical therapy. Six to eight weeks later, all subjects will undergo regenerative treatment with the use of a bone substitute, a collagen membrane and fixation pins, and in control group tissues will heal following the non-submerged protocol, meanwhile subjects in test group will undergo submerged healing. Six months later, subjects in test group will have their prostheses reconnected to the regenerated implants. All patients will undergo periodontal and peri-implant maintenance therapy every three months during follow-up. Radiographic assessment of vertical bone level changes (primary outcome), clinical status of peri-implant tissues, changes in soft tissues margin, patient related outcomes and adverse events will be assessed at 3, 6 and 12 months after peri-implantitis regenerative surgery.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28040
        • Dental School, University Complutense of Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients diagnosed of peri-implantitis requiring surgical therapy
  • The periapical radiographic study demonstrates an intra-bony component greater than 3 mm at the affected implant
  • There is at least 2 mm of keratinized mucosa around the affected implant
  • Intrasurgically, peri-implant defects must be type Ia, Ib, Ic and Ie (according to Schwarz et al. 2007)
  • Affected implants must be two-piece implants to allow for the submerged protocol
  • Affected implant supported restorations must be screw-retained or cemented, and should allow for prostheses removal

Exclusion Criteria:

  • Patients with untreated periodontitis
  • Medical conditions requiring prolonged use of steroids and/or medications that can interfere with bone metabolism
  • Metabolic disorders such as osteoporosis
  • History of uncontrolled endocrine disorders
  • History of leukocyte dysfunction and deficiencies
  • History of immunodeficiency syndromes
  • History of neoplastic disease requiring the use of radiation of chemotherapy
  • History of renal failure
  • Physical handicaps that would interfere with the ability to perform adequate oral hygiene
  • Alcoholism or drug abuse
  • Smokers of more than 10 cigarettes per day, cigar equivalents or tobacco chewers
  • Any other condition or circumstance that, in the opinion of the investigator, would prevent completion of study participation or interfere with the analysis of the study results, such as history of non-compliance or unreliability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Submerged healing
Bone regeneration of peri-implantitis defects following a submerged healing
Bone regeneration of peri-implantitis defects using a bone xenograft and a resorbable collagen membrane, with flap suturing using a submerged healing protocol
ACTIVE_COMPARATOR: Non-submerged healing
Bone regeneration of peri-implantitis defects following a non-submerged healing
Bone regeneration of peri-implantitis defects using a bone xenograft and a resorbable collagen membrane, with flap suturing using a non-submerged healing protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in radiographic bone fill
Time Frame: Baseline, 3 months, 6 months and 12 months post-surgery
Changes in radiographic bone fill measured from the implant shoulder to the first bone to implant contact with ImageJ software, in parallelized periapical x-rays with individual silicone bite blocks
Baseline, 3 months, 6 months and 12 months post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in pocket probing depth
Time Frame: At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Depth of the peri-implant sulcus/pocket measured in millimeters with a 15-UNC (University of North Carolina) periodontal probe, at six sites per implant without the crown
At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Changes in bone probing depth
Time Frame: At baseline, after non-surgical therapy and 12 months post-surgery
Distance from the mucosal margin to the peri-implant bone measured in millimeters with a 15-UNC (University of North Carolina) periodontal probe under local anesthesia, at six sites per implant without the crown
At baseline, after non-surgical therapy and 12 months post-surgery
Changes in modified plaque index
Time Frame: At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Presence or absence of plaque assessed at six sites per tooth/implant in the whole mouth, excluding third molars
At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Changes in full mouth bleeding scores
Time Frame: At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Presence or absence of bleeding after probing with a 15-UNC (University of North Carolina) periodontal probe, assessed at six sites per tooth/implant in the whole mouth, excluding third molars. The presence of bleeding in each site will be scored 1, and the absence of bleeding will be scored 0. Full mouth bleeding score will be expressed in percentage and calculated as follows: number of sites bleeding / number of sites explored ^ 100
At baseline, after non-surgical therapy, 6 months and 12 months post-surgery
Soft tissue healing scores
Time Frame: 1 week, 2 weeks and 4 weeks post-surgery

Extent of soft tissue healing after surgery following Landry et al. Healing Index (1988):

  • Healing index 1 - Very Poor
  • Healing index 2 - Poor
  • Healing index 3 - Good
  • Healing index 4 - Very good
  • Healing index 5 - Excellent
1 week, 2 weeks and 4 weeks post-surgery
Pain assessment
Time Frame: 1 week, 2 weeks and 4 weeks post-surgery
Participants´ subjective pain assessed using a Visual Analogue Scale (VAS) with ratings from 0-10, whereof 0 = no pain and 10 = very intense.
1 week, 2 weeks and 4 weeks post-surgery
Oral Health Impact Profile (OHIP-14)
Time Frame: Baseline, 3 months, 6 months and 12 months post-surgery
Self-reported dysfunction, discomfort and disability attributed to the participants´ oral condition
Baseline, 3 months, 6 months and 12 months post-surgery
Adverse events´ occurrence
Time Frame: Up to 12 months post-surgery
Occurrence of any untoward, undesired or unplanned event in the form of signs, symptoms, disease, or laboratory or physiologic observations occurring in a subject participant in the clinical investigation. The event does not nee to be casually related to the cliinical investigation
Up to 12 months post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mariano Sanz, MD DDS DrMed, University Complutense of Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

April 1, 2019

Primary Completion (ANTICIPATED)

May 1, 2021

Study Completion (ANTICIPATED)

May 1, 2021

Study Registration Dates

First Submitted

April 1, 2019

First Submitted That Met QC Criteria

April 1, 2019

First Posted (ACTUAL)

April 3, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 4, 2019

Last Update Submitted That Met QC Criteria

April 2, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peri-Implantitis

Clinical Trials on Submerged healing

Subscribe